Evidence map›Paper›PMID 35168140›Full record

ArticleNeuroImage. Clinical2022

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.

Marina Buciuc, Peter R Martin, Nirubol Tosakulwong, Melissa E Murray, Leonard Petrucelli, Matthew L Senjem, Anthony J Spychalla, David S Knopman, Bradley F Boeve, Ronald C Petersen and 6 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Evaluating the updated LATE-NC staging criteria using data from NACC.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Marina BuciucDepartment of Neurology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: buciuc.marina@mayo.edu.
Peter R MartinDepartment of Quantitative Health Sciences, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: martin.peter1@mayo.edu.
Nirubol TosakulwongDepartment of Quantitative Health Sciences, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: tosakulwong.nirubol@mayo.edu.
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA. Electronic address: murray.melissa@mayo.edu.
Leonard PetrucelliDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA. Electronic address: petrucelli.leonard@mayo.edu.
Matthew L SenjemDepartment of Radiology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: Senjem.matthew1@mayo.edu.
Anthony J SpychallaDepartment of Radiology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: spychalla.anthony@mayo.edu.
David S KnopmanDepartment of Neurology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: knopman@mayo.edu.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: bboeve@mayo.edu.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: peter8@mayo.edu.
Joseph E ParisiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: parisi.joseph@mayo.edu.
R Ross ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: Reichard.robert@mayo.edu.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA. Electronic address: Dickson.dennis@mayo.edu.
Clifford R JackDepartment of Radiology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: jack.clifford@mayo.edu.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: Whitwell.jennifer@mayo.edu.
Keith A JosephsDepartment of Neurology, Mayo Clinic, 200 1(st) Street NW, Rochester, MN 55905, USA. Electronic address: josephs.keith@mayo.edu.
Mayo Clinic in Florida · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI Walter K. Kremers · 2019 to 2026
$33.5M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Understanding the role of TDP-43 in Alzheimers disease and FTLDR01AG037491 · NIA · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2024
$6.5M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasRF1NS120992 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Keith A Josephs, Mercedes Prudencio · 2021 to 2026
$4.2M
NIA NIH HHS P30 AG062677NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG037491NIA NIH HHS R01 AG041851NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786NINDS NIH HHS RF1 NS120992
6 · The paper itself

Abstract

Transactive response DNA-binding protein of ∼43 kDa (TDP-43), a primary pathologic substrate in tau-negative frontotemporal lobar degeneration (FTLD), is also often found in the brains of elderly individuals without FTLD and is a key player in the process of neurodegeneration in brains with and without FTLD. It is unknown how rates and trajectories of TDP-43-associated brain atrophy compare between these two groups. Additionally, non-FTLD TDP-43 inclusions are not homogeneous and can be divided into two morphologic types: type-α and neurofibrillary tangle-associated type-β. Therefore, we explored whether neurodegeneration also varies due to the morphologic type. In this longitudinal retrospective study of 293 patients with 843 MRI scans spanning over ∼10 years, we used a Bayesian hierarchical linear model to quantify similarities and differences between the non-FTLD TDP-43 (type-α/type-β) and FTLD-TDP (n = 68) in both regional volume at various timepoints before death and annualized rate of atrophy. Since Alzheimer's disease (AD) is a frequent co-pathology in non-FTLD TDP-43, we further divided types α/β based on presence/absence of intermediate-high likelihood AD: AD-TDP type-β (n = 90), AD-TDP type-α (n = 104), and Pure-TDP (n = 31, all type-α). FTLD-TDP was associated with faster atrophy rates in the inferior temporal lobe and temporal pole compared to all non-FTLD TDP-43 groups. The atrophy rate in the frontal lobe was modulated by age with younger FTLD-TDP having the fastest rates. Older FTLD-TDP showed a limbic predominant pattern of neurodegeneration. AD-TDP type-α showed faster rates of hippocampal atrophy and smaller volumes of amygdala, temporal pole, and inferior temporal lobe compared to AD-TDP type-β. Pure-TDP was associated with slowest rates and less atrophy in all brain regions. The results suggest that there are differences and similarities in longitudinal brain volume loss between FTLD-TDP and non-FTLD TDP-43. Within FTLD-TDP age plays a role in which brain regions are the most affected. Additionally, brain atrophy regional rates also vary by non-FTLD TDP-43 type.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaFrontotemporal Lobar DegenerationAgedAtrophyBayes TheoremBrainDNA-Binding ProteinsHumansRetrospective StudiesDNA-Binding ProteinsTARDBP protein, humanAlzheimer’s diseaseLATEMRIOld age FTLDTDP-43

Identifiers

PMID35168140
PMCPMC8850800
OpenAlexW4210815435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.